Neptune Acquires 6.75M Class A Common Shares in Capital of Acasti Pharma for C$2.30/Share
July 13, 2013 at 13:52 PM EDT
Neptune Technologies & Bioressources (NASDAQ: NEPT ) announces today it has acquired, through the exercise of a previously issued warrant, 6,750,000 Class A common shares in the capital of Acasti Pharma, a majority-owned subsidiary of Neptune. The Shares were acquired at a price of CDN$2.30 per Share upon the
